Related Experiment Videos
Different DNA changes in primary and recurrent hepatocellular carcinoma.
S F Ding1, R P Jalleh, C B Wood
1University Department of Surgery, Royal Free Hospital School of Medicine, London.
Gut
|October 1, 1992
Summary
Hepatocellular carcinoma (HCC) recurrence was investigated using DNA analysis. Findings suggest the recurrent tumor arose independently, indicating a new cancer, not a relapse.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Hepatocellular carcinoma (HCC) is a primary liver cancer.
- Understanding tumor recurrence is crucial for patient management.
- DNA analysis can differentiate primary tumors from recurrences.
Observation:
- DNA restriction fragment length polymorphism (RFLP) analysis was performed on primary and recurrent HCC in a hepatitis B virus-negative patient.
- Allele losses were observed on chromosomes 17p and 5q in the primary tumor.
- The recurrent tumor exhibited distinct allele losses on chromosomes 17p, 12q, and DNA rearrangement on 1q.
Findings:
- The primary and recurrent HCC showed different patterns of allele loss and DNA rearrangement.
- The recurrent tumor displayed allele loss with probes Lambda MS43 (12q24.3-qter) and pYNZ22 (17p13), and DNA rearrangement with Lambda MS32 (1q42-43).
- These genetic differences indicate the recurrent tumor is a de novo neoplasm.
Implications:
- The findings suggest the recurrent HCC represents an independent tumor, not a direct recurrence of the primary lesion.
- This distinction is vital for accurate diagnosis and treatment strategies for HCC.
- Further research into the genetic basis of de novo HCC development is warranted.